BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
27.03
-0.86 (-3.08%)
At close: Nov 17, 2026
| Market Cap | 11.76B -49.3% |
| Revenue (ttm) | 1.34B +13.8% |
| Net Income | 102.28M +64.8% |
| EPS | 0.24 +62.2% |
| Shares Out | 435.23M |
| PE Ratio | 112.24 |
| Forward PE | n/a |
| Dividend | 0.02 (0.06%) |
| Ex-Dividend Date | Jun 9, 2026 |
| Volume | 5,909,735 |
| Open | 27.79 |
| Previous Close | 27.89 |
| Day's Range | 26.70 - 27.99 |
| 52-Week Range | 27.03 - 72.88 |
| Beta | 0.35 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 30, 2026 |